Delaware Street Capital Master Fund, L.p. - Net Worth and Insider Trading
Delaware Street Capital Master Fund, L.p. Net Worth
The estimated net worth of Delaware Street Capital Master Fund, L.p. is at least $2 Million dollars as of 2024-09-20. Delaware Street Capital Master Fund, L.p. is the 10% Owner of Zevra Therapeutics Inc and owns about 255,995 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $2 Million. Details can be seen in Delaware Street Capital Master Fund, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Delaware Street Capital Master Fund, L.p. has not made any transactions after 2018-10-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Delaware Street Capital Master Fund, L.p.
Delaware Street Capital Master Fund, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Delaware Street Capital Master Fund, L.p. owns 2 companies in total, including Zevra Therapeutics Inc (ZVRA) , and Neos Therapeutics Inc (NEOS) .
Insider Ownership Summary of Delaware Street Capital Master Fund, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2018-10-05 | 10 percent owner |
| NEOS | Neos Therapeutics Inc | 2015-07-28 | 10 percent owner |
Delaware Street Capital Master Fund, L.p. Latest Holdings Summary
Delaware Street Capital Master Fund, L.p. currently owns a total of 1 stock. Delaware Street Capital Master Fund, L.p. owns 255,995 shares of Zevra Therapeutics Inc (ZVRA) as of October 5, 2018, with a value of $2 Million.
Latest Holdings of Delaware Street Capital Master Fund, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2018-10-05 | 255,995 | 8.04 | 2,058,200 |
Holding Weightings of Delaware Street Capital Master Fund, L.p.
Delaware Street Capital Master Fund, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Delaware Street Capital Master Fund, L.p. has made a total of 0 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 125,000 shares on October 5, 2018, which cost Delaware Street Capital Master Fund, L.p. around $6 Million.
Insider Trading History of Delaware Street Capital Master Fund, L.p.
- 1
Delaware Street Capital Master Fund, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Delaware Street Capital Master Fund, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Delaware Street Capital Master Fund, L.p. is -16.61%. GuruFocus also compares Delaware Street Capital Master Fund, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Delaware Street Capital Master Fund, L.p. within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Delaware Street Capital Master Fund, L.p.'s insider trading performs compared to the benchmark.
Performance of Delaware Street Capital Master Fund, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.11 | | | | | |
| Relative Return to S&P 500(%) | 14.86 | | | | | |
Delaware Street Capital Master Fund, L.p. Ownership Network
Delaware Street Capital Master Fund, L.p. Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Delaware Street Capital Master Fund, L.p. is the 10 percent owner of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include VP Fin & Corp Controller R. Laduane Clifton , director & President and CEO Neil F. Mcfarlane , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Delaware Street Capital Master Fund, L.p. made no insider transaction in Zevra Therapeutics Inc (ZVRA). Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 30,000 shares made by John B Bode , a net purchase of 5,740 shares made by R. Laduane Clifton , and a net purchase of 1,000 shares made by Watton Corey Michael .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 22,000 shares, with a net purchase of 22,000 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 58,240 shares were bought by its insiders, resulting in a net purchase of 58,240 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Delaware Street Capital Master Fund, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Delaware Street Capital Master Fund, L.p.. You might contact Delaware Street Capital Master Fund, L.p. via mailing address: 900 N. Michigan, Suite 1600, Chicago Il 60611.
Discussions on Delaware Street Capital Master Fund, L.p.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
